for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

BRIEF-Y-mAbs Announces Initiation Of Submission Of Omburtamab Rolling Biologics License Application To FDA

June 30 (Reuters) - Y-mAbs Therapeutics, Inc:

* Y-MABS ANNOUNCES INITIATION OF SUBMISSION OF OMBURTAMAB ROLLING BIOLOGICS LICENSE APPLICATION TO THE FDA

* Y-MABS THERAPEUTICS, - EXPECTS TO PRESENT RESULTS OF PHASE 2 STUDIES 101 AND 03-133 LATER THIS YEAR Source text for Eikon: Further company coverage:

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up